Faulty Epigenetic Switch Disrupts Brain Cell Cycles and Drives White Matter Defects in Autism-Linked Disorders

A single gene that helps package DNA inside cells has emerged as a surprising linchpin of brain wiring, and when it goes wrong, the consequences ripple through the entire architecture of the developing brain. In a study published in Experimental & Molecular Medicine, an international team of researchers traced how pathogenic variants in MSL2, a core component of a histone-modifying complex, sabotage the production of myelin, the fatty insulation that lets electrical signals race along nerve fibers. The work connects a rare neurodevelopmental syndrome to a precise molecular failure inside oligodendrocyte precursor cells, the stem-like cells responsible for wrapping axons in myelin, and it does so with a level of mechanistic detail that has been missing from the field.

The clinical starting point came from three patients with neurodevelopmental disorders who carried damaging MSL2 variants. Two harbored protein-truncating variants, one a de novo frameshift and one a stop-gain mutation with undetermined inheritance, while the third carried a de novo 83-kilobase microdeletion spanning both MSL2 and the neighboring PCCB gene. All three children presented with moderate to severe intellectual disability, language impairment, and motor delay, and two showed autism or autistic features. Critically, magnetic resonance imaging revealed white matter abnormalities in every patient, ranging from a thin corpus callosum and punctate frontal hyperintensities in the oldest patient to diffuse symmetrical T2 hyperintensity, ventricular enlargement, and widespread polymicrogyria in a seven-month-old infant. The consistency of these imaging findings across patients with different mutation types underscored white matter vulnerability as a hallmark of MSL2-related disease.

To probe what the variants actually do to cells, the team turned to immortalized lymphocytes available from the patient carrying the microdeletion. Western blotting and immunofluorescence showed markedly reduced MSL2 protein compared with four age- and sex-matched healthy controls, and the levels of two histone marks that MSL2 helps regulate, H4K16ac and H3K4me3, trended downward in the patient’s cells. These marks are chemical embellishments on histone proteins that flag chromatin as open and transcriptionally active, so their reduction signaled that the mutation genuinely impairs MSL2’s epigenetic function rather than merely removing one copy of the gene. The finding gave the researchers a molecular fingerprint to hunt for in the brain.

That hunt required a new animal model, because mice lacking Msl2 from conception die as embryos, masking any role the gene plays in specific cell types. The team instead crossed mice carrying a floxed Msl2 allele with Olig1-Cre mice, deleting a critical exon that encodes both the N-terminal RING finger domain and the C-terminal CXC domain, thereby producing a loss-of-function mutation exclusively in the oligodendrocyte lineage. Quantitative PCR and western blotting confirmed that Msl2 expression collapsed in purified precursor cells from these conditional knockouts, while MSL2 protein remained intact in mature neurons, proving the deletion was cell-type specific. The researchers also tracked where and when MSL2 acts normally, finding that Msl2 transcripts were far more abundant in white matter structures such as the corpus callosum and optic nerve than in cortex at postnatal day 7, peaked in the first two postnatal weeks, and were highest in newly formed oligodendrocytes before declining in mature myelin-producing cells.

What happened when the gene was removed was striking. The density of SOX10-positive oligodendrocyte lineage cells was normal at birth but fell significantly from postnatal day 7 through day 50 in both the corpus callosum and the cortex. The proportion of CC1-positive mature oligodendrocytes dropped, myelin basic protein levels declined sharply, and electron microscopy at postnatal day 40 revealed fewer myelinated axons with thinner myelin sheaths and higher g-ratios, a quantitative measure of reduced myelin thickness. TUNEL assays ruled out increased cell death, but EdU incorporation showed far fewer proliferating precursor cells in the mutants, and fewer of the cells that did incorporate EdU went on to become MBP-positive oligodendrocytes. In purified cultures treated with thyroid hormone to drive differentiation, Msl2-deficient cells showed intrinsically reduced capacity to become CNPase- and MBP-positive oligodendrocytes, and an inducible knockout triggered at the onset of differentiation still impaired maturation, indicating that MSL2 is required both for proper cell division and for the initiation of differentiation.

The behavioral fallout mirrored the cellular damage. In the three-chamber sociability test, mutant mice showed no preference for a stranger mouse over an empty chamber and failed to recognize social novelty, while the resident-intruder test revealed strong social avoidance and the self-grooming test revealed repetitive behavior, together recapitulating the core diagnostic domains of autism spectrum disorder. Open field and elevated plus maze tests showed heightened anxiety, the tail suspension test and sucrose preference test indicated depressive-like states, and notably, novel object recognition remained intact, suggesting that cognition was spared even as social and emotional behaviors were disrupted. This constellation of social withdrawal, repetitive grooming, and comorbid anxiety and depression makes the conditional knockout a potentially valuable model for studying how epigenetically regulated myelin contributes to autism.

The mechanistic core of the study came from integrated transcriptomic and epigenomic profiling of purified precursor cells. RNA sequencing identified 1,166 genes upregulated and 327 downregulated after Msl2 loss, and gene ontology analysis of the downregulated set pointed squarely at cell cycle, cell division, mitotic spindle, and myelin sheath terms. Among the affected genes were Aspm, a microcephaly-associated spindle assembly factor; Tpx2, which nucleates spindle microtubules; and Bub1b, a kinase essential for the spindle-assembly checkpoint. Cell synchronization experiments made the consequence concrete: while nearly 70 percent of phospho-histone H3-positive control cells reached metaphase, only about 25 percent of mutant cells did, with most stalling in prophase or prometaphase and metaphase cells displaying loose chromosome compaction, triple or multipolar spindles, and twisted spindle architectures. Meanwhile, the upregulated genes were enriched for inflammatory response, innate immune response, and cytokine activity, with chemokines such as Cxcl1, Cxcl2, Ccl4, and Ccl20 elevated, hinting that MSL2 loss may endow precursor cells with immunomodulatory properties that could exacerbate neuroinflammation.

Epigenomic mapping revealed which histone mark carries the weight. ChIP-seq for H3K4me3 showed that although the genomic distribution of peaks was broadly preserved, peak signals dropped dramatically near transcription start sites after Msl2 deletion, and genes losing the mark were enriched for myelination, oligodendrocyte differentiation, cell proliferation, and mitotic G2/M transition terms. Cross-referencing with the transcriptome showed that 177 genes with reduced H3K4me3 were also transcriptionally downregulated, accounting for nearly 36 percent of all downregulated genes. By contrast, H4K16ac, the canonical product of the MSL-MOF complex, was only mildly reduced and overlapped with just 12 percent of downregulated genes, while H2BK120ub, an indirect target of MSL2’s ubiquitin ligase activity, showed minimal concordance with either H3K4me3 loss or transcriptional change. The data collectively reposition H3K4me3, rather than H4K16ac, as the dominant downstream effector of MSL2 in oligodendrocyte lineage cells.

Proteomics added an unexpected twist to the mechanism. Co-immunoprecipitation coupled with mass spectrometry identified 160 MSL2-interacting proteins in precursor cells, including the expected partner KAT8, also known as MOF, but also ASH2L and RBBP5, the core subunits of the COMPASS-like H3K4 methyltransferase complex, and SOX10, the master transcription factor of the oligodendrocyte lineage. Western blotting on MSL2 immunoprecipitates validated all of these interactions. This suggests a previously unrecognized model in which MSL2 physically recruits the H3K4 methylation machinery to myelination and cell cycle genes, with SOX10 potentially guiding the complex to its oligodendrocyte-specific targets, independent of MSL2’s E3 ubiquitin ligase activity toward H2B.

The implications extend well beyond a rare syndrome. Because MSL2 governs the transition from proliferating precursor cells to differentiating oligodendrocytes rather than lineage commitment itself, modulating MSL2 complex activity could, in principle, enhance myelination programs not only in MSL2-related neurodevelopmental disorders but also in conditions involving demyelination. The study’s authors caution that more than 60 percent of downregulated genes did not show significant H3K4me3 reduction, leaving room for additional mechanisms such as H3K79 methylation or MSL2’s proposed role in protecting regulatory regions from DNA methylation. Still, by linking patient genetics, cell-autonomous mouse genetics, cell cycle biology, and chromatin profiling into a single coherent story, the work transforms MSL2 from a gene of uncertain function into a defined epigenetic regulator of the brain’s insulation, and it offers the white matter defects seen on MRI in affected children their first clear molecular explanation.

Subject of Research: The role of the chromatin regulator MSL2 in oligodendrocyte precursor cell cycle control, H3K4me3-mediated gene regulation, and white matter defects in neurodevelopmental disorders.

Article Title: MSL2 orchestrates oligodendrocyte precursor cell cycle via H3K4me3 to prevent white matter defects in neurodevelopmental disorders

Article References: Yuan, J., Dong, Y., Zhang, K., Wei, Z., Zhang, Z., Zhang, M., Luo, S., Jiang, S., Peng, Y., Wu, X., Yvan, H., Goel, H., Zhang, E., The Australian Undiagnosed Diseases Network (UDN-Aus), Guo, H., Wu, S., & Zhao, X. (2026). MSL2 orchestrates oligodendrocyte precursor cell cycle via H3K4me3 to prevent white matter defects in neurodevelopmental disorders. Experimental & Molecular Medicine. https://doi.org/10.1038/s12276-026-01858-1

Image Credits: AI Generated

DOI: 10.1038/s12276-026-01858-1

Keywords: MSL2, oligodendrocytes, H3K4me3, myelination, neurodevelopmental disorders, autism spectrum disorder, white matter, epigenetics, cell cycle, mitotic spindle, conditional knockout mice, chromatin regulation